Cloud Banner

Healthcare

Image

Global Maternal Blood Test Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Maternal Blood Test Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 13% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 3.81 Billion
Diagram Market Size (Forecast Year) USD 10.12 Billion
Diagram CAGR 13%

Global Maternal Blood Test Market, By Type (Combined First Trimester Screening, Second Trimester Maternal Serum Screening), Tested Conditions (Edwards Syndrome, Patau Syndrome, Down syndrome, Neural Tube Defects), End-User (Diagnostic Laboratories, Hospitals) – Industry Trends and Forecast to 2030.

Maternal Blood Test Market

Maternal Blood Test Market Analysis and Size

One of the major factors driving the growth of the maternal blood test market is the continuous improvement in the reimbursement scenario for NIPT around the world. An increase in the incidence of chromosomal abnormalities, combined with increasing product usage in new applications, drive market growth. The growing preference for non-invasive techniques over invasive methods, as well as an increase in programmes aimed at raising NIPT awareness, all have an impact on the market.

Data Bridge Market Research analyses that the maternal blood test market which was USD 3.807  billion in 2022, is expected to reach USD 10.12 billion by 2030, at a CAGR of 13.00% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Maternal Blood Test Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Combined First Trimester Screening, Second Trimester Maternal Serum Screening), Tested Conditions (Edwards Syndrome, Patau Syndrome, Down syndrome, Neural Tube Defects), End- User (Diagnostic Laboratories, Hospitals)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

CENTOGENE N.V. (Germany), SEQUENOM (U.S.), Natera, Inc. (U.S.), LifeLabs Genetics (Canada), Sema4 OpCo, Inc. (U.S.), Invitae Corporation (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), General Electric (U.S.), PerkinElmer Inc. (U.S.), Agilent Technologies, Inc. (U.S.), BGI (China), F. Hoffmann-La Roche Ltd (Switzerland), YOURGENE HEALTH (U.K.), Eurofins Scientific (Luxembourg), EKF Diagnostics (Germany)

Market Opportunities

  • Introduction of NIPTs

Market Definition

A maternal blood test is a type of prenatal screening test that determines the likelihood that a chromosome disorder will impact a pregnancy or certain behavioural issues will impact a pregnancy. The primary goal of the test is to ensure that the baby does not have any chromosomal abnormalities such as Down syndrome. These tests are known to be capable of providing more information about pregnancy health.

Global Maternal Blood Test Market Dynamics

Drivers

  • Rising use of maternal blood tests

Maternal blood tests can detect and diagnose chromosomal rearrangements, X-linked diseases, and aid in the reduction of spontaneous abortions, increased implantation rates, the prevention of trisomic offspring, and the avoidance of the risk of transmitting single gene disorders. However, PGS and PGD results are not 100% accurate, and if necessary, diagnostic tests such as amniocentesis and CVS must be performed after pregnancy to confirm the positive PGS/PGD results. In the United States alone, more than 63,000 babies were born through IVF in 2013, an increase of 2,000 births from 2012. These are the certain test that help the market to grow.

Opportunities

  • Introduction of NIPTs

The introduction of NIPTs using cell-free foetal DNA (cffDNA) in 2011 was the most significant advancement in the field of prenatal screening. Obstetricians and patients who are put off by ultrasound screening's 10% to 15% false positive rate and maternal serum test's 5% false positive rate are eagerly embracing NIPTs that claim to have only a 5% false positive rate. In just four years, molecular genetics companies have successfully developed eight different types of kits for detecting genetic abnormalities in foetus. These products have gradually marginalized maternal serum tests, and maternal serum tests are expected to become obsolete within the next decade.

Restraints/Challenges

  • Lack of skilled professionals

Lack of skilled and trained professionals, strict regulatory guidelines and ethical stumbling blocks limits the market's growth during the forecast period.

This maternal blood test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the maternal blood test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Maternal Blood Test Market Scope

The maternal blood test market is segmented on the basis of type, tested condition and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Combined First Trimester Screening
  • Second Trimester Maternal Serum Screening

 Tested Conditions

  • Edwards Syndrome
  • Patau Syndrome
  • Down syndrome
  • Neural Tube Defects

End-User

  • Diagnostic Laboratories
  • Hospitals

Maternal Blood Test Market Regional Analysis/Insights

The maternal blood test market is analyzed and market size insights and trends are provided by country, type, tested condition and end-user as referenced above.

The countries covered in the maternal blood test market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the maternal blood test market because of the high adoption of advanced technologies within the region. 

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the developing healthcare infrastructure, and increasing awareness programs and conferences in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The maternal blood test market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for maternal blood test market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the maternal blood test market. The data is available for historic period 2011-2021.

Competitive Landscape and Maternal Blood Test Market Share Analysis

The maternal blood test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to maternal blood test market.

Some of the major players operating in the maternal blood test market are:

  • CENTOGENE N.V. (Germany)
  • SEQUENOM (U.S.)
  • Natera, Inc. (U.S.)
  • LifeLabs Genetics (Canada)
  • Sema4 OpCo, Inc. (U.S.)
  • Invitae Corporation (U.S.)
  • Illumina, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • General Electric (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • BGI (China)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • YOURGENE HEALTH (U.K.)
  • Eurofins Scientific (Luxembourg)
  • EKF Diagnostics (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Maternal Blood Test Market is projected to grow at a CAGR of 13.00% during the forecast period by 2030.
The future market value of the Maternal Blood Test Market is expected to reach USD 10.12 billion by 2030.
The major players in the Maternal Blood Test Market are CENTOGENE N.V. (Germany), SEQUENOM (U.S.), Natera, Inc. (U.S.), LifeLabs Genetics (Canada), Sema4 OpCo, Inc. (U.S.), Invitae Corporation (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), etc.
The countries covered in the Maternal Blood Test Market are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials